HEPATIC ONCOLOGY : Impact Factor & More
eISSN: 2045-0931pISSN: 2045-0923
Open AccessShare this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on HEPATIC ONCOLOGY
HEPATIC ONCOLOGY Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | FUTURE MEDICINE LTD |
| Language | English |
| Frequency | Quarterly |
| Article Processing Charges | USD 1415 |
| Publication Time | 13 |
| Editorial Review Process | Double anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 2014 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in HEPATIC ONCOLOGY ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in HEPATIC ONCOLOGY
Treatment patterns and outcomes in US patients with unresectable HCC treated with embolization.
- 19 Oct 2026
- Hepatic oncology
Patient characteristics to guide personalized treatment decisions and prognostication in hepatocellular carcinoma
- 26 Sep 2026
- Hepatic Oncology
Racial and ethnic survival disparities in primary liver cancer in the United States: a National Cancer Database propensity score-matched study
- 12 Sep 2026
- Hepatic Oncology
Advances in liver transplantation for hepatic malignancies.
- 17 Jun 2026
- Hepatic oncology
RTA‑408 induces p38‑dependent apoptosis and suppresses cell viability in hepatocellular carcinoma cells.
- 27 Apr 2026
- Hepatic oncology
Characteristics of hepatocellular carcinoma in a Saudi tertiary care center: a 10-year retrospective study
- 1 Jan 2026
- Hepatic Oncology
Treatment patterns and outcomes in US patients with unresectable HCC treated with embolization.
- 19 Oct 2026
- Hepatic oncology
Patient characteristics to guide personalized treatment decisions and prognostication in hepatocellular carcinoma
- 26 Sep 2026
- Hepatic Oncology
Racial and ethnic survival disparities in primary liver cancer in the United States: a National Cancer Database propensity score-matched study
- 12 Sep 2026
- Hepatic Oncology
Advances in liver transplantation for hepatic malignancies.
- 17 Jun 2026
- Hepatic oncology
RTA‑408 induces p38‑dependent apoptosis and suppresses cell viability in hepatocellular carcinoma cells.
- 27 Apr 2026
- Hepatic oncology
Characteristics of hepatocellular carcinoma in a Saudi tertiary care center: a 10-year retrospective study
- 1 Jan 2026
- Hepatic Oncology
FAQs on HEPATIC ONCOLOGY
How long has HEPATIC ONCOLOGY been actively publishing? 
What is the publishing frequency of HEPATIC ONCOLOGY?
How many articles did HEPATIC ONCOLOGY publish last year?
What is the eISSN & pISSN for HEPATIC ONCOLOGY?
Who is the publisher of HEPATIC ONCOLOGY?
